WANG Jiepeng, LI Ruihong, JIA Bingchen, YU Zhe, CAO Junnan, PU Ke, YANG Lilin, ZHAO Liping, SUN Hao
Abstract (
)
Download PDF (
)
Knowledge map
Save
Esophageal benign stricture has become a common digestive disease with the improvement of public health awareness. The implantation of an esophageal stent remains the main clinical method to relieve obstruction and improve swallowing. In recent years, biodegradable stents have received increasing attention because they can gradually degrade after fulfilling their function and avoid secondary removal. Among them, biodegradable magnesium alloy stents show great potential due to favorable bio-compatibility, controllable degradation, and ion release capacity. To address the rapid corrosion of magnesium alloys in physiological environments, various strategies have been adopted. Alloying has been used to refine micro-structures and improve corrosion resistance. Surface modification methods, such as micro-arc oxidation, polymer coatings, and composite functional layers, have provided protective barriers and enabled controlled ion release. Structural optimization of stents has also been carried out to achieve a better match between mechanical strength, flexibility, and degradation behavior. These approaches have led to significant improvements in corrosion resistance, bio-compatibility, controlled release, and mechanical compatibility. With the development of biomedical materials and tissue engineering, biodegradable magnesium alloy stents have become a research hot spot. Many in vitro and in vivo studies have confirmed their safety and therapeutic potential. However, challenges remain, including precise control of degradation rate, maintenance of mechanical integrity, and reliable evaluation of long-term biological responses. Future research will likely focus on multifunctional coatings, drug delivery systems, and advanced manufacturing technologies to accelerate clinical translation. In conclusion, biodegradable magnesium alloy stents represent a promising direction for the treatment of esophageal benign stricture. Current progress has demonstrated their feasibility, while ongoing research continues to provide insights into their application and future development.